The U.S. Sucralfate Market Is Estimated To Witness High Growth Owing To Trend Of Rising Prevalence Of Peptic Ulcers

U.S. Sucralfate Market

Sucralfate is an aluminum hydroxide complex of sucrose octasulfate. It acts as a protective agent and forms an ulcer-healing complex with proteins at the ulcer site. Sucralfate demonstrates cytoprotective properties by forming a physical barrier at the gastric mucosa that shields the underlying tissue from acid assault and pepsin activity. It also stimulates prostaglandin formation to increase mucosal blood flow and aids in ulcer healing. Sucralfate is used to treat stomach ulcers, gastroesophageal reflux disease (GERD), and other gastrointestinal ulcers or erosions.

The U.S. Sucralfate Market is estimated to be valued at US$ 60.8 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
One of the key trends fueling the growth of the U.S. sucralfate market is the rising prevalence of peptic ulcers in the country. Peptic ulcers are open sores or ulcers that develop in the lining of the esophagus, stomach, or the first part of the small intestine. A few common risk factors that contribute to the rising incidence of peptic ulcers include excessive consumption of non-steroidal anti-inflammatory drugs (NSAIDs), smoking, excessive alcohol intake, bacterial infection with H. pylori, and stress. According to the American Gastroenterological Association, about 15 million Americans suffer from peptic ulcers each year. The higher occurrence of ulcers would correspondingly boost the demand for sucralfate in the U.S. ulcer healing market.

Porter’s Analysis

Threat of new entrants: The threat of new entrants in the U.S. sucralfate market is low as it requires high investment in R&D and manufacturing facilities. Bargaining power of buyers: The bargaining power of buyers is moderate as sucralfate is available on prescription and there are few substitutes available. Bargaining power of suppliers: The bargaining power of suppliers is moderate as the raw materials required are commodity products and suppliers have the threat of forward integration. Threat of new substitutes: New substitutes pose low threat as sucralfate offers unique mechanism of action for treatment of ulcers. Competitive rivalry: Intense as major players compete on brand recognition, quality and pricing.

SWOT Analysis
Strength: Sucralfate offers gastric protection without systemic absorption and has fewer side effects. Wide range of drugs available in tablet, suspension and syrup forms.

Weakness: Requires frequent dosing. Taste of sucralfate formulations is generally unpalatable.

Opportunity: Increasing prevalence of peptic ulcers and GERD presents growth opportunities. New innovative formulations can improve patient compliance.

Threats: Generic competition poses pricing pressure. Safety concerns over long-term usage can impact demand.

Key Takeaways
The global U.S. Sucralfate Market Size is expected to witness high growth, exhibiting CAGR of 4.2% over the forecast period, due to increasing prevalence of peptic ulcers in the country. Regionally, the western U.S. holds the largest share currently due to higher awareness and faster adoption of new drugs. The northeast U.S. is expected to be the fastest growing market due to rising healthcare expenditures.

Key players operating in the U.S. sucralfate market are Sanofi, Teva Pharmaceutical Industries, Taro Pharmaceuticals, Mylan N.V., and Perrigo Company PLC. Sanofi dominates the market with over 30% share due to its wide portfolio of branded sucralfate products. Teva Pharmaceutical Industries holds the second largest market share with generic sucralfate drugs.

Explorer more information on this topic, Please visit @ https://www.dailyprbulletin.com/new-avenue-for-u-s-sucralfate-market-growth


Comments

Post a Comment

Popular posts from this blog

Optical Transport Network Market Is Estimated To Witness High Growth Owing To Opportunity In Deployment Of 400G Systems

Image
Optical Transport Network Market  Optical transport network (OTN) refers to the transport of data, voice and video traffic over long distances using optical technologies. OTN solutions facilitate transmission bandwidth rates ranging from 10Gbit/s to over 100Gbit/s over existing fiber infrastructure. They deploy advanced multiplexing techniques such as dense wave division multiplexing (DWDM) and time-division multiplexing (TDM) that boost transmission and switching capabilities. OTN solutions deliver reduced latency and enhanced reliability for meeting rising bandwidth demands. The global Optical Transport Network Market is estimated to be valued at US$ 22.32 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The rising deployment of 400G networks across internet data centers and telecom backbones is estimated to present lucrative growth opportuniti...
Read more

Ostomy Care Accessories Market Is Estimated To Witness High Growth Owing To Opportunity In Improving Patient Lifestyles

Image
Ostomy Care Accessories Market Ostomy accessories are medical devices used along with an ostomy appliance or pouching system to help improve the quality of life of people who have had ostomy surgery. Some common ostomy accessories include belt or pants/undergarment clips, skin barriers, moisture-collecting bags, adhesive removers, and protecting sheets. The growing number of patients suffering from inflammatory bowel disease, colorectal cancer, and other gastrointestinal disorders have resulted in increasing demand for ostomy care accessories. These accessories play a crucial role in providing security, discretion, and comfort to ostomates while performing regular activities. The global Ostomy Care Accessories Market is estimated to be valued at US$ 3.69 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Improving patient lifestyles is one of the major...
Read more

Schmallenberg Virus Treatment Is Estimated To Witness High Growth Owing To Opportunity Of Development Of New Drugs And Vaccines

Image
Schmallenberg Virus Treatment Market Schmallenberg virus (SBV) is an orthobunyavirus that affects domestic and wild ruminants such as cattle, sheep and goats. The virus causes fever, diarrhea and decreased milk production in adult animals. In newborn animals, the virus can lead to arthrogryposis-hydranencephaly syndrome, which causes malformations of the limbs and heads. While there is currently no treatment for SBV infection, supportive treatment measures such as nutritional supplements can help address symptoms such as diarrhea and reduced milk production. Researchers are developing preventive drugs and vaccines to control the spread of the virus. The global Schmallenberg Virus Treatment Market is estimated to be valued at US$ 110 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The key opportunity for growth in the Schmallenberg virus treatment marke...
Read more